摘要:
There is described novel hindered amine salts of 6,7 dihalo-3,4-dihydro-3 -oxo-2-quinoxaline carboxylic acids of the formula I: wherein R and R 1 are independently halogen; R 2 is H, CH 3 , or C 2 H 5 ; R 3 , when taken singly, is H, CH 3 , C 2 H 5 , C 2 H 4 OH, CH 2 C 6 H 5 or CH 2 COOC 2 H 5 ; R 4 , when taken singly, is a hindered hydrocarbyl radical of the group consisting of cycloactyl, norbornyl, Ad and CHR 2 Ad wherein Ad is a 1-adamantyl, a 2-adamantyl, a 3-(4-homoiso) twistane or a tricycloundecane radical; and R 3 and R 4 when taken together with the nitrogen to which they are attached, form an adamantylspiropyrrolidine radical. The compounds are prepared by treatment of the free acid with the free base or a salt of the appropriate hindered amine. They are effective antiviral agents in mammels.
摘要:
3-Amino-4-homoisotwistane derivatives of the formula, wherein R 1 is hydrogen or an alkyl or alkenyl group, and R 2 is an alkyl or alkenyl group, or non-toxic pharmaceutically acceptable salts thereof, are prepared by reacting a 3-R 1 -amino-4-homoisotwistane with R 3 X where R 3 is alkyl, alkenyl, carboalkoxy or alkanoyl and X is halogeno and reducing any carboalkoxy or alkanoyl group in the reaction product to an alkyl group or are prepared by reacting 3-bro- mo-4-homoisotwistane with R 1 R 2 NH. The compounds and salts, which can be formulated into pharmaceutical compositions, are valuable as antiviral agents for animals and useful for the treatment of perkinsonean disease.
摘要:
The invention relates to novel compounds that have S1P receptor modulating activity and, preferably, apoptotic activity and/or anti proliferative activity against cancer cells and other cell types. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, cancer. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as cancer.
摘要:
Neue urethangruppenhaltige (Meth)Acrylate, die in ein- und demselben Molekül eine (Meth)Acrylat- gruppe und eine Urethangruppe sowie weitere andere polymerisierbare Gruppen enthalten und sowohl radikalisch und/oder kationisch polymerisieren können, werden zur Herstellung von Beschichtungen, Klebstoffen, Photoresists, Lötstoppmasken oder in der Stereolothographie verwendet. Die daraus hergestellten Formkörper enthalten ein zusammenhängendes, homogenes Netzwerk und weisen hohe Festigkeitseigenschaften, vorallem mechanische Eigenschaften, auf.
摘要:
A process for the preparation of tricyclic compounds is described in which novel intermediate compounds of the general formula in which R represents hydrogen or alkyl having up to 5 carbons, the dotted line represents an optional carbon-carbon bond and OR' represents a leaving group is cyclised using an alkali metal in an organic solvent, followed, if desired, by hydrogenation to give compounds of the formulae Compounds of formula I and VI are useful as odoriferous agents having patchouli type odours and, with the exception of norpatchoulenol, are new.